JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

ZNF224 enhances the oncogenic function of p21 via p53 and AKT pathways in melanoma

  • 0Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
The Febs Journal +

|

May 5, 2025

|

May 5, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Zinc finger protein 224 (ZNF224) drives melanoma progression by enhancing p21(CIP1/WAF1) activity. This study reveals ZNF224

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Zinc finger protein 224 (ZNF224) expression is deregulated in cancers, correlating with poor prognosis.
  • ZNF224 mediates transforming growth factor beta (TGF-β)-induced pro-tumoral activities in melanoma.
  • Understanding ZNF224's molecular mechanisms in melanoma is crucial for therapeutic development.

Purpose Of The Study

  • To investigate the molecular mechanisms of ZNF224's oncogenic role in melanoma.
  • To elucidate how ZNF224 influences cell growth, apoptosis, and drug resistance.
  • To explore the relationship between ZNF224, p21(CIP1/WAF1), and p53 in melanoma.

Main Methods

  • Investigated ZNF224 overexpression effects on melanoma cell lines.
  • Assessed ZNF224's impact on cyclin-dependent kinase inhibitor 1 [p21(CIP1/WAF1)] transcription and function.
  • Analyzed p53-dependent modulation and AKT pathway involvement.
  • Examined transcriptomic data from human melanoma tissues.

Main Results

  • ZNF224 overexpression increased melanoma cell growth and reduced drug-induced apoptosis.
  • ZNF224 positively modulated p21(CIP1/WAF1) gene transcription in a p53-dependent manner.
  • ZNF224 enhanced AKT-triggered oncogenic effects of p21(CIP1/WAF1) via cytosolic retention, promoting proliferation and inhibiting apoptosis.
  • Human melanoma data confirmed a link between ZNF224 and p21(CIP1/WAF1) when p53 is functional.

Conclusions

  • ZNF224 promotes melanoma tumorigenesis by dysregulating p21(CIP1/WAF1) function in a p53-dependent manner.
  • The identified ZNF224-p21(CIP1/WAF1) axis offers potential therapeutic targets for melanoma.
  • This research deepens the understanding of melanoma progression and identifies novel therapeutic strategies.

Keywords:

Related Concept Videos

NF-κB-dependent Signaling Pathway 02:26

7.2K

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Intrinsic Apoptotic Pathway 01:31

5.5K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

MAPK Signaling Cascades 01:07

4.9K

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Abnormal Proliferation 02:23

4.3K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Interactions Between Signaling Pathways 01:19

6.1K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...